Return to pperkins.org

PATRICIA PERKINS

SUMMARY

Director/Deputy Director with extensive and diversified experience in: healthcare operations; strategic planning/ fundraising/ budgetary management, feasibility and needs assessment; quantitative and qualitative analysis; curriculum development; teaching and training of healthcare workers; and process improvement in the healthcare industry and academic medical training settings. Expertise in infectious diseases, drug treatment delivery, and pediatric asthma care to medically marginalized communities in four US cities, and vaccine and maternal child health program introduction in Ecuador and Egypt. Accomplished public speaker and trainer, undergraduate and healthcare sciences educator, and author of peer-reviewed and lay medical publications. Demonstrated leadership in partnering with senior management, including non-profit board members, for quality improvement and outcomes management. Results include increased profitability, enhanced patient/client services, and quality outcomes. Excellent written, verbal communication and problem solving skills, with ability to influence cross-functional and cross-cultural teams through motivational management.

PROFESSIONAL EXPERIENCE (1994-present only, others available upon request)

Grant-funded division of health education and health sciences academic department within major California State University and second largest California community college. Allied and public health training programs emphasize culturally and linguistically competent care to medically indigent persons.

Development of new and expanded allied healthcare programs through California community college system, including training programs for existing allied healthcare workforce.

• Interface with community college deans and healthcare training staff in a five-county Bay Area region (see: www.healthoccupations.org).
• Serve as lead author, co-author, facilitator and co-investigator of outcomes development and management for federal, state, and private industry and foundation grant-funded nursing, imaging technology, and healthcare interpreter programs. Funding sources include: The California Endowment; the federal Department of Labor and the Carl D. Perkins VTEA program; the federal Department of Education; Kaiser Permanente; the California Department of Health Services; the Chancellors’ Office of the California Community Colleges; the Gordon & Betty Moore Foundation.
• Serve as Associate Director for SF County’s participation in a statewide pediatric asthma initiative with senior staff from SF Department of Public Health, as subcontractor partner (see: www.dhs.ca.gov/ps/cdic/cdcb/medicine/asthma/).
• Teach and guest lecture in biological science and public health courses developed for allied healthcare workforce, including nurses, physician assistants, other undergraduates
• Co-supervise staff of three part-time student assistants and mentor to MPH students.

Provide senior analysis, clinical trial management, financial and program development, and fundraising consulting services to/for-profit and non-profit healthcare, biotechnology, video game and film production clients in four US cities. Recruited by LA, Texas and Washington, DC area consulting firms as well as directly through non-profits, county agencies, medical clinics and academic medical centers.

Senior Consultant

Provide organizational management, fundraising, outcomes design and measurement, and write and edit narrative text for print, web-based and video based medical and education materials.

• Served as primary fundraiser for federal, state, corporate and foundation donors for Bay Area and Southern California-based healthcare non-profits. Secured $14 million in grant funding.
• Served as interim director for two Bay Area healthcare non-profits while director worked on European assignments/projects for two-year period. Secured and co-managed $450K in grant funds.
• Provided technical support, development of outcomes management system, facilitated and wrote strategic plan, provide majority of written content for federal accreditation of LA and NYC-based drug treatment programs. Program received three-year accreditation approval in February 2003.
• Write and edit narrative content for infectious disease curriculum and web-based educational materials for healthcare web sites: www.hcvadvocate.org, www.oasisclinic.org, and others.
• Write and edit sections of narrative content for Santa Barbara County Hepatitis C Strategic Plan; see: www.sbhcvtaskforce.org/plan.htm
• Facilitate small and large group trainings on HIV and hepatitis C in California, New York, and Texas to multi-cultural populations, outreach workers and union members, in English and Spanish.
• Write, produce 5 minute public service segments and appear as local expert on substance abuse issues for LA-area Persian community on North American feed of Farsi-language broadcast Iranian TV : http://www.irtv.com.

11-clinic system of heroin addiction and primary medical care clinics in four California counties

Director for Program Development/Grants & Contracts Officer

Write and develop grant and contract proposals for federal, state, foundation, and pharmaceutical donors. Serve as co-investigator in infectious diseases clinical research studies, including mentoring and supervision of medical, graduate and undergraduate students, and management of research study funds.

• Competed and secured $250K of new pharmaceutical company funding of HIV and HCV studies; served as study co-investigator in mentoring medical students. Conducted data design and analysis, study write-up, abstract submission, and public presentation of data findings at three US scientific meetings.
• Maintained & expanded to $5.5M state and local funding base particularly for HIV funding in LA area.
• Served as Ryan-White (federal grant funding) peer reviewer for City/County of San Francisco.
• Served as technical lead, prepared narrative content and data analysis for successful receipt of 3-year federal accreditation of two of the system’s eleven clinics, including writing narrative content of annual management report, available on-line at www.baartcdp.com.

Largest provider of primary and tertiary medical care in the Tri-State area. Largest provider of HIV primary medical care services Manhattan. Largest provider of outpatient drug treatment in the US. Teaching hospital for Albert Einstein College of Medicine.

Project and Program Director TB/DOPT Project, AIDS Program, Dept. of Medicine 1994-1997

Implementation, conduct, and supervision of all operational aspects of four-year federally funded TB screening and HIV testing/counseling program for two cohorts of drug users, one in a community based harm reduction, syringe exchange setting; the second in an inpatient drug detoxification and HIV primary care clinic.

• Secured additional $500K of foundation and state support for program.
• Prepared scientific abstracts and papers for publication/presentation at US and oversees academic meetings. Presentation of major scientific findings to medical and lay public, including media.
• Budget development, management and oversight of all aspects of program.
• Supervision of staff of eight paraprofessional clinic staff (PAs), research assistants, and data analyst(s).

EDUCATION

Certificate in Infectious Diseases Modeling, London School of Hygiene & Tropical Medicine: 2005

Doctoral level course work: Epidemiology & Immunology & Infectious Diseases:1987-1990

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (left due to family illness)

Master of Health Sciences (now MPH/MS) Population Dynamics

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD: 1988

Internship, Maternal Child Health, Family Planning and Refugee Health: 1987, summer 1988, 1989

Population Council, Cairo, Egypt (Headquarters: New York, NY)

Bachelor of Arts, Political Science/English

Vassar College, Poughkeepsie, NY

PROFESSIONAL CONSULTING/OUTSIDE ACTIVITIES (HIGHLIGHTS)

City and County of San Francisco Peer Grant Reviewer: HIV Prevention and HIV Treatment Programs for Ryan White Care Act Funding: June 2005; Feb. 2005; November 1999

California Community Colleges Chancellors’ Office Grant Reviewer for Healthcare and Special Populations: November 2004, February 2005, August 2005

Community Advisory Board Member, Center for AIDS Prevention Studies, UCSF, San Francisco, CA

(includes peer reviews and internal grant reviews; www.caps.ucsf.edu:11/03 & 1/05)

Member, JSPAC, State of California Federal VTEA Grant # 03-0342-001: www.casp.cc

Board Member, APAN, Project of ACRC, Redwood City, CA: www.acrc.org

Community Advisory Board Member, OASIS, Oakland, CA: www.oasisclinic.org

Technical Advisor and Producer on Healthcare Documentary Films/Videos, California & Vancouver, BC

Member, State of California Strategic Planning Working Group on Hepatitis C

Mentor and Career Advisor to Johns Hopkins School of Public Health and Vassar College Students

Co-investigator for NYC based Women Interagency HIV Study (WIHS)

Peer Reviewed Publications

1. Sylvestre DL, Aron R, Greene DR, Perkins P. Treating hepatitis C in recovering injection drug users (abstract #2886). Gastroenterology 2001;120:A-568.
2. Salomon N, Perlman DC, Friedmann P, Perkins MP, Ziluck V, Des Jarlais DC, Paone D. Knowledge of tuberculosis among drug users. Relationship to return rates for tuberculosis screening at a syringe exchange. J Subst Abuse Treat. 1999 April 16 (3): 229-35.
3. Paone D, Perlman DC, Perkins MP, Kochems LM, Salomon N, Des Jarlais DC. Organizational issues in conducting tuberculosis screening at a syringe exchange program. J Subst. Abuse Treat. 1998 May-June; 15 (3): 229-34.
4. Perlman DC, Perkins MP, Salomon N, Kochems L, Des Jarlais DC, Paone D. Tuberculosis screening at a syringe exchange program. Am J Public Health. 1997 May; 87 (5): 862-3.
5. Perlman DC, Perkins MP, Paone D, Kochems L, Salomon N, Friedmann P, Des Jarlais DC "Shotgunning" as an illicit drug smoking practice. J Subst Abuse Treat. 1997 Jan-Feb; 14(1): 3-9.
6. Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC. Tuberculosis in drug users. Clin Infect Dis. 1995 Nov.; 21 (5): 1253-64. Review.

Abstracts & Presentations (academic/conference only since June, 1997; selected from a list of 144; please see web site: www.pperkins.org for other presentations on Hepatitis C)

• Cowans S, Herrick G, Cohn K, Perkins MP, Lo D, Medina L, Legion V. Improved Identification of Children at Risk for Pediatric Asthma in an Urban Setting. To be presented at the 132nd APHA Annual Meeting, Washington, DC: November 9, 2004 (Abstract #92949; Session #4123.0.)
• Perkins P and State of California EWD Healthcare Initiative RHORC Directors: Bridging the Gap: Meeting the Health Industry Needs Via Collaborative Response: The California EWD Healthcare Initiative RHORCs. Presented at the California Workforce Association Spring 2004 Conference, San Diego, CA, April 6, 2004. Conference Co-sponsored by California WIB, US Department of Labor, CCC EWD, and the California Association for Local Economic Development.
• Perkins P, Zorn L, DiAngelo M. Ambulatory Care Nursing Training & Technical Assistance: Forging Partnerships between Primary Care, Public Health & Academia. Presented at the CCCAOE & CCCCIO (California Community Colleges) Spring 2004 Joint Conference, San Francisco, CA, March 4, 2004.
• Perkins MP, Cohn K, Legion V. Impact of a health-educator driven environmental assessment survey as a tool to improve public housing standards and minimize environmental triggers of respiratory illness. Presented at the 131st APHA Annual Meeting, San Francisco, CA: November 19, 2003 (Abstract #74779; Session #5023.0).
• Perkins MP, Legion V, Tsai C. Replicating Chronic Disease Medicaid Managed Care Reimbursement Models for Payment of Adult and Pediatric Asthma Case Management. Presented at the National Conference on Asthma 2003, Washington, DC: June 2003.
• Sylvestre DL, Clements B, Perkins P. Treating Hepatitis C in Recovering Injection Drug Users on Methadone. Presented at the AASLD 52nd Annual Liver Meeting, Dallas, TX, November 2001.
• Sylvestre D, Schwartzapfel B, Aron R, Perkins MP. Treating Hepatitis C in Recovering Injection Drug Users. Presented at Digestive Diseases Week, Atlanta, GA, May 2001. Presented in Modified Format at: American Liver Foundation/OASIS First Annual Forum on HCV in Injection Drug Users, Oakland, CA Feb. 2001; American Public Health Association (APHA), Boston, MA, November 2000; 49th Annual Meeting of the American Society of Tropical Medicine & Hygiene, Houston, TX, November 2000; 3rd National Harm Reduction Conference, October 2000, Miami, FLA; and the American Methadone Treatment Assoc. Bi-Annual Conference, SF, CA April 2000.
• Perkins P, Spencer, L, Sellers, A. Hepatitis C Virus Antibody Testing, Follow-up and Clinical Management among In-Treatment Drug Users: A Preliminary Report from an SF MMT Program. Presented at the APHA Annual Conference, Boston, MA, November 2000; in a Modified Format at 3rd National Harm Reduction Conference, October 2000, Miami, FL.
• Perlman DC, Salomon N, Garcia de Soria V, Perkins MP, Lugo W, Ojeda L, Friedmann P, Des Jarlais DC, Paone D. TB directly observed preventive therapy for active drug users in two settings. Presented at 1997 CPDD 59th Annual Scientific Meeting, Nashville, TN June 1997.
• Salomon N, Perlman DC, Friedmann P, Perkins MP, Garcia de Soria V, Ojeda L, Lugo W, Des Jarlais DC. Tuberculin reactivity among drug users varies by years of injection but not by specific drug or route of use. Presented at 1997 CPDD 59th Annual Scientific Meeting, Nashville, TN June 1997.